Who owns KALA PHARMACEUTICALS INC?

Tip: Access positions for across all investors

Analyze quarterly positions in Kala Pharmaceuticals with up to 7 years of data, all consolidated into one spreadsheet

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Top investors of Kala Pharmaceuticals stock

Who bought or sold KALA PHARMACEUTICALS INC this quarter?

Fund or Company Name Shares Held Valued At Change in Shares As Of Actions
Baker Bros. Advisors 985k $1.5M -18% Sep 2025
 View chart
Woodline Partners 224k $125k -9% Dec 2025
 View chart
Jane Street 144k $80k 100% Dec 2025
 View chart
ADAR1 Capital Management 142k $79k 0% Dec 2025
 View chart
Vanguard Group 91k $51k -57% Dec 2025
 View chart
Virtu Financial 86k $48k 100% Dec 2025
 View chart
Geode Capital Management 61k $34k -10% Dec 2025
 View chart
Renaissance Technologies 41k $23k 100% Dec 2025
 View chart
State Street Corporation 29k $16k 0% Dec 2025
 View chart
XTX Topco 28k $16k 100% Dec 2025
 View chart
UBS Group 24k $13k 192% Dec 2025
 View chart
BlackRock 21k $12k 0% Dec 2025
 View chart
Marex Group 15k $35k 100% Sep 2025
 View chart
Two Sigma Securities 13k $7.3k 100% Dec 2025
 View chart
Intl Fcstone 12k $6.8k 100% Dec 2025
 View chart
Northern Trust 12k $6.4k 0% Dec 2025
 View chart
SG Americas Securities 10k $6.0k 100% Dec 2025
 View chart
Covestor 1.3k $999.950400 0% Dec 2025
 View chart
Caitong International Asset Management 736.00 $1.1k 100% Sep 2025
 View chart
MAI Wealth Advisors 300.00 $167.010000 0% Dec 2025
 View chart
Steward Partners Investment Advisory 120.00 $66.996000 0% Dec 2025
 View chart
International Assets Investment Management 110.00 $60.995000 100% Dec 2025
 View chart
Jpmorgan Chase & Co 51.00 $77.713800 100% Sep 2025
 View chart
Legacy Wealth Managment 25.00 $14.000000 0% Dec 2025
 View chart
SBI Securities 8.00 $12.000000 0% Sep 2025
 View chart

Who sold out of Kala Pharmaceuticals?

Fund or Company Name Date Sold Shares Held Valued At
UBS O'Connor Jun 2025 139k $660k
Perceptive Advisors Jun 2025 55k $263k
Tower Research Capital Sep 2025 5.1k $7.8k
Pnc Financial Services Sep 2025 46.00 $69.998200